Trafficking and proteolytic processing of APP

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 5, 2012, Pages

  Haass, Christian ^a,b   Kaether, Christoph ^c   Thinakaran, Gopal ^d   Sisodia, Sangram ^d  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; GAMMA SECRETASE; NEU DIFFERENTIATION FACTOR; AMYLOID PRECURSOR PROTEIN; METALLOPROTEINASE; SECRETASE;

ARTICLE; CELL MIGRATION; CELLULAR DISTRIBUTION; DISEASE COURSE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PHOSPHORYLATION; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; NERVE CELL; PHYSIOLOGY; PROTEIN TRANSPORT; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; HUMANS; METALLOPROTEASES; MUTATION; NEURONS; PROTEIN TRANSPORT; PROTEOLYSIS;

EID: 84862633779     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006270     Document Type: Article

References (194)

1. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, DelacourteA, Dingwall C, De Strooper B, Dotti CG. 2004. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167: 953-960.
2. Allinson TM, Parkin ET, Turner AJ, Hooper NM. 2003. ADAMs family members as amyloid precursor protein α-secretases. J Neurosci Res 74: 342-352.
3. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK. 2005. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20: 187-198.
4. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CA, Breiderhoff T, Jansen P, Wu X, et al. 2005. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci 102: 13461-13466.
5. Ando K, Iijima KI, Elliott JI, Kirino Y, Suzuki T. 2001. Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J Biol Chem 276: 40353-40361.
6. Annaert W, De Strooper B. 1999. Presenilins: Molecular switches between proteolysis and signal transduction. Trends Neurosci 22: 439-443.
7. Back S, Haas P, Tschape JA, Gruebl T, Kirsch J, Muller U, Beyreuther K, Kins S. 2007. Beta-amyloid precursor protein can be transported independent of any sorting signal to the axonal and dendritic compartment. J Neurosci Res 85: 2580-2590.
8. Basi G, Frigon N, Barbour R, Doan T, Gordon G, McConlogue L, Sinha S, ZellerM. 2003. Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. J Biol Chem 278: 31512-31520.
9. Beach TG, Kuo YM, Schwab C, Walker DG, Roher AE. 2001. Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine. Neurosci Lett 310: 21-24.
10. Beher D, Elle C, Underwood J, Davis JB, Ward R, Karran E, Masters CL, Beyreuther K, Multhaup G. 1999. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J Neurochem 72: 1564-1573.
11. Benjannet S, Elagoz A, Wickham L, Mamarbachi M, Munzer JS, Basak A, LazureC, Cromlish JA, Sisodia S, Checler F, et al. 2001. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem 276: 10879-10887.
12. Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, Vassar R. 2000a. Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem 275: 20647-20651.
13. Bennett BD, Denis P, Haniu M, Teplow DB, Kahn S, Louis JC, Citron M, Vassar R. 2000b. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta-secretase. J Biol Chem 275: 37712-37717.
14. Birchmeier C, Nave KA. 2008. Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56: 1491-1497.
15. Brown MS, Ye J, Rawson RB, Goldstein JL. 2000. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 100: 391-398.
16. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, ShelineYI, Klunk WE, Mathis CA, Morris JC, et al. 2005. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25: 7709-7717.
17. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. 1993. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci 90: 2092-2096.
18. Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ, Greengard P. 1990. Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci 87: 6003-6006.
19. Buxbaum JD, Thinakaran G, Koliatsos V, O'Callahan J, Slunt HH, Price DL, Sisodia SS. 1998a. Alzheimer amyloid protein precursor in the rat hippocampus: Transport and processing through the perforant path. J Neurosci 18: 9629-9637.
20. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA. 1998b. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273: 27765-27767.
21. Cai XD, Golde TE, Younkin SG. 1993. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259: 514-516.
22. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. 2001. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4: 233-234.
23. Cam JA, Zerbinatti CV, Li Y, Bu G. 2005. Rapid endocytosis of the LDL receptor-related protein modulates cell surface distribution and processing of the beta amyloid precursors protein. J Biol Chem 280: 15464-15470.
24. Cao X, Sudhof TC. 2001. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293: 115-120.
25. Capell A, Steiner H, Willem M, Kaiser H, Meyer C, Walter J, Lammich S, Multhaup G, Haass C. 2000. Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem 275: 30849-30854.
26. Capell A, Meyn L, Fluhrer R, Teplow DB, Walter J, Haass C. 2002. Apical sorting of beta-secretase limits amyloid beta-peptide production. J Biol Chem 277: 5637-5643.
27. Carey RM, Balcz BA, Lopez-Coviella I, Slack BE. 2005. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol 6: 30.
28. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, et al. 1991. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353: 844-846.
29. Chavez-Gutierrez L, Tolia A, Maes E, Li T, Wong PC, de Strooper B. 2008. Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity. J Biol Chem 283: 20096-20105.
30. Chyung JH, Selkoe DJ. 2003. Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem 278: 51035-51043.
31. Chyung JH, Raper DM, Selkoe DJ. 2005. Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 280: 4383-4392.
32. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM. 2005. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48: 913-922.
33. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM. 2008. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58: 42-51.
34. Citron M. 2004. Beta-secretase inhibition for the treatment of Alzheimer's disease-promise and challenge. Trends Pharmacol Sci 25: 92-97.
35. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. 1992. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672-674.
36. Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ. 2003. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci 100: 11735-11740.
37. Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, Craessaerts K, Annaert W, De Strooper B. 2001. Processing of beta-secretase by furin and other members of the proprotein convertase family. J Biol Chem 276: 4211-4217.
38. Cupers P, Bentahir M, Craessaerts K, Orlans I, Vanderstichele H, Saftig P, De Strooper B, Annaert W. 2001. The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein. J Cell Biol 154: 731-740.
39. De Strooper B, Craessaerts K, Dewachter I, Moechars D, Greenberg B, Van Leuven F, Van den Berghe H. 1995a. Basolateral secretion of amyloid precursor protein in Madin-Darby canine kidney cells is disturbed by alterations of intracellular pH and by introducing a mutation associated with familial Alzheimer's disease. J Biol Chem 270: 4058-4065.
40. De Strooper B, Craessaerts K, Van Leuven F, Van Den Berghe H. 1995b. Exchanging the extracellular domain of amyloid precursor protein for horseradish peroxidase does not interfere with alpha-secretase cleavage of the beta-amyloid region, but randomizes secretion in Madin-Darby canine kidney cells. J Biol Chem 270: 30310-30314.
41. De Strooper B, Iwatsubo T, Wolfe MS. 2011. Presenilins and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006304.
42. De Vos KJ, Grierson AJ, Ackerley S, Miller CC. 2008. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173.
43. Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K, et al. 2005. Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J Biol Chem 280: 30797-30806.
44. Dries DR, Yu G. 2008. Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease. Curr Alzheimer Res 5: 132-146.
45. Dries DR, Shah S, Han YH, Yu C, Yu S, Shearman MS, Yu G. 2009. GLU333 of nicastrin directly participates in gamma-secretase activity. J Biol Chem 284: 29714-29724.
46. Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K. 1988. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7: 949-957.
47. Edbauer D, Winkler E, Haass C, Steiner H. 2002. Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci 99: 8666-8671.
48. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C. 2003. Reconstitution of gamma-secretase activity. Nat Cell Biol 5: 486-488.
49. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. 2003. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160: 113-123.
50. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ. 1990. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248: 1122-1124.
51. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H. 2000. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci 97: 9712-9717.
52. Fluhrer R, Capell A, Westmeyer G, Willem M, Hartung B, Condron MM, TeplowDB, Haass C, Walter J. 2002. A non-amyloidogenic function of BACE-2 in the secretory pathway. J Neurochem 81: 1011-1020.
53. Fluhrer R, Grammer G, Israel L, Condron MM, Haffner C, Friedmann E, BohlandC, Imhof A, Martoglio B, Teplow DB, et al. 2006. A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nat Cell Biol 8: 894-896.
54. Fluhrer R, Fukumori A, Martin L, Grammer G, Haug-Kroper M, Klier B, WinklerE, Kremmer E, Condron MM, Teplow DB, et al. 2008. Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation. J Biol Chem 283: 30121-30128.
55. Fluhrer R, Steiner H, Haass C. 2009. Intramembrane proteolysis by signal peptide peptidases: A comparative discussion of GXGD-type aspartyl proteases. J Biol Chem 284: 13975-13979.
56. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, Nicoll M, MaxwellM, Hai B, Ellis MC, et al. 2002. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3: 85-97.
57. Frykman S, Hur JY, Franberg J, Aoki M, Winblad B, Nahalkova J, Behbahani H, Tjernberg LO. 2010. Synaptic and endosomal localization of active gamma-secretase in rat brain. PloS One 5: e8948.
58. Fukumori A, Okochi M, Tagami S, Jiang J, Itoh N, Nakayama T, Yanagida K, Ishizuka-Katsura Y, Morihara T, Kamino K, et al. 2006. Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45: 4907-4914.
59. Gandy S, Greengard P. 1994. Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis. Biochimie 76: 300-303.
60. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. 1992. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255: 728-730.
61. Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, Keller P, Biernat J, Mandelkow E, Mandelkow EM. 2006. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 7: 873-888.
62. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. 1997. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 41: 402-404.
63. Grimm HS, Beher D, Lichtenthaler SF, Shearman MS, Beyreuther K, Hartmann T. 2003. Gamma-secretase cleavage site specificity differs for intracellular and secretory amyloid beta. J Biol Chem 278: 13077-13085.
64. Gu Y, Misonou H, Sato T, Dohmae N, Takio K, Ihara Y. 2001. Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem 276: 35235-35238.
65. Gusnard DA, Raichle ME, Raichle ME. 2001. Searching for a baseline: Functional imaging and the resting human brain. Nat Rev Neurosci 2: 685-694.
66. Haass C. 2004. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 23: 483-488.
67. Haass C, Selkoe DJ. 1993. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75: 1039-1042.
68. Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
69. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. 1992a. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357: 500-503.
70. Haass C, Scholssmacher M, Hung AY, Vigo-Pelfrey C, Mellon A, OstaszewskiB, Liederburg I, Koo F, Schenk D, Teplow D, et al. 1992b. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
71. Haass C, Hung AY, Schlossmacher MG, Oltersdorf T, Teplow DB, Selkoe DJ. 1993a. Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann NY Acad Sci 695: 109-116.
72. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. 1993b. Beta-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024.
73. Haass C, Koo EH, Teplow DB, Selkoe DJ. 1994. Polarized secretion of beta-amyloid precursor protein and amyloid beta-peptide in MDCK cells. Proc Natl Acad Sci 91: 1564-1568.
74. Haass C, Koo EH, Capell A, Teplow DB, Selkoe DJ. 1995a. Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol 128: 537-547.
75. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ. 1995b. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1: 1291-1296.
76. Harris JA, Devidze N, Halabisky B, Lo I, Thwin MT, Yu GQ, Bredesen DE, Masliah E, Mucke L. 2010. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 30: 372-381.
77. Harrison SM, Harper AJ, Hawkins J, Duddy G, Grau E, Pugh PL, Winter PH, Shilliam CS, Hughes ZA, Dawson LA, et al. 2003. BACE1 (beta-secretase) transgenic and knockout mice: Identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci 24: 646-655.
78. Hartmann T, Bergsdorf C, Sandbrink R, Tienari PJ, Multhaup G, Ida N, Bieger S, Dyrks T, Weidemann A, Masters CL, et al. 1996. Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicing. J Biol Chem 271: 13208-13214.
79. Hasegawa H, Sanjo N, Chen F, Gu YJ, Shier C, Petit A, Kawarai T, Katayama T, Schmidt SD, Mathews PM, et al. 2004. Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. J Biol Chem 279: 46455-46463.
80. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K, et al. 2002. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11: 2615-2624.
81. He X, Li F, Chang WP, Tang J. 2005. GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem 280: 11696-11703.
82. Hill K, Li Y, Bennett M, McKay M, Zhu X, Shern J, Torre E, Lah JJ, Levey AI, KahnRA. 2003. Munc18 interacting proteins: ADP-ribosylation factor-dependent coat proteins that regulate the traffic of beta-Alzheimer's precursor protein. J Biol Chem 278: 36032-36040.
83. Hock C, Maddalena A, Raschig A, Muller-Spahn F, Eschweiler G, Hager K, Heuser I, Hampel H, Muller-Thomsen T, Oertel W, et al. 2003. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease. Amyloid 10: 1-6.
84. Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J. 2000. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290: 150-153.
85. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPA-R removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52: 831-843.
86. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R. 2006. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9: 1520-1525.
87. Huse JT, Pijak DS, Leslie GJ, Lee VM, Doms RW. 2000. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J Biol Chem 275: 33729-33737.
88. Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, TewDG, Meek TD, Chapman C, Schneider K, et al. 2000. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci 16: 609-619.
89. Inoue E, Deguchi-Tawarada M, Togawa A, Matsui C, Arita K, Katahira-TayamaS, Sato T, Yamauchi E, Oda Y, Takai Y. 2009. Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. J Cell Biol 185: 551-564.
90. Kaether C, Skehel P, Dotti CG. 2000. Axonal membrane proteins are transported in distinct carriers: A two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell 11: 1213-1224.
91. Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, Steiner H, HaassC. 2002. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158: 551-561.
92. Kaether C, Haass C, Steiner H. 2006a. Assembly, trafficking and function of gamma-secretase. Neurodegener Dis 3: 275-283.
93. Kaether C, Schmitt S, Willem M, Haass C. 2006b. Amyloid precursor protein and notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7: 408-415.
94. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. 2001. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414: 643-648.
95. Kamenetz F, Tomita T, Seabrook G, Borchelt D, Iwatsubo T, Sisodia SS, Malinow R. 2003. APP processing and synaptic function. Neuron 37: 925-937.
96. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
97. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM, Woolf CJ, et al. 2007. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9: 755-764.
98. Kins S, Lauther N, Szodorai A, Beyreuther K. 2006. Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease. Neurodegener Dis 3: 218-226.
99. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci 98: 5815-5820.
100. Koo EH, Squazzo SL. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389.
101. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, FischerP, Masters CL, Price DL. 1990. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci 87: 1561-1565.
102. Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF. 2010. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29: 3020-3032.
103. Lai A, Sisodia SS, Trowbridge IS. 1995. Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain. J Biol Chem 270: 3565-3573.
104. Lakshmana MK, Yoon IS, Chen E, Bianchi E, Koo EH, Kang DE. 2009. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid beta peptide generation. J Biol Chem 284: 11863-11872.
105. LaVoie MJ, Fraering PC, Ostaszewski BL, Ye W, Kimberly WT, Wolfe MS, SelkoeDJ. 2003. Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J Biol Chem 278: 37213-37222.
106. Lazarov O, Lee M, Peterson DA, Sisodia SS. 2002. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22: 9785-9793.
107. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, DeBoer SR, Koliatsos VE, Kins S, Lee VM, Wong PC, et al. 2005. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: Revisited. J Neurosci 25: 2386-2395.
108. Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, Neve R, Ahlijanian MK, Tsai LH. 2003. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163: 83-95.
109. Lesne S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. 2005. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25: 9367-9377.
110. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van DuinenSG, Bots GT, Luyendijk W, Frangione B. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124-1126.
111. Lichtenthaler SF, Haass C, Steiner H. 2011. Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing. J Neurochem 117: 779-796.
112. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. 2000. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci 97: 1456-1460.
113. Lo AC, Haass C, Wagner SL, Teplow DB, Sisodia SS. 1994. Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J Biol Chem 269: 30966-30973.
114. Lu DC, Soriano S, Bredesen DE, Koo EH. 2003. Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity. J Neurochem 87: 733-741.
115. Luo Y, Bolon B, Damore MA, Fitzpatrick D, Liu H, Zhang J, Yan Q, Vassar R, Citron M. 2003. BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol Dis 14: 81-88.
116. Mackenzie IR, Miller LA. 1994. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 87: 504-510.
117. Maltese WA, Wilson S, Tan Y, Suomensaari S, Sinha S, Barbour R, McConlogueL. 2001. Retention of the Alzheimer's amyloid precursor fragment C99 in the endoplasmic reticulum prevents formation of amyloid beta-peptide. J Biol Chem 276: 20267-20279.
118. Marcinkiewicz M, Seidah NG. 2000. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 75: 2133-2143.
119. Marquez-Sterling NR, Lo ACY, Sisodia SS, Koo EH. 1997. Trafficking of cell-surface beta-amyloid precursor protein: Evidence that a sorting intermediate participates in synaptic vesicle recycling. J Neurosci 17: 140-151.
120. Martin L, Fluhrer R, Haass C. 2009. Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis. J Biol Chem 284: 5662-5670.
121. Matthews V, Schuster B, Schutze S, Bussmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen KJ, et al. 2003. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 278: 38829-38839.
122. Merlos-Suarez A, Fernandez-Larrea J, Reddy P, Baselga J, Arribas J. 1998. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J Biol Chem 273: 24955-24962.
123. Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. 2006. The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci 29: 280-285.
124. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RHJr., Brown H, Tiwari A, Hayward L, et al. 2009. Axonal transport defects in neurodegenerative diseases. J Neurosci 29: 12776-12786.
125. Mucke L, Selkoe DJ. 2011. Neurotoxicity of amyloid β-protein: Synaptic and network dysfunction. Cold Harbor Perspect Med doi: 10. 1101/cshperspect. a006338.
126. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1: 345-347.
127. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. 2001. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced A-beta protofibril formation. Nat Neurosci 4: 887-893.
128. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258: 304-307.
129. Nitsch RM, Farber SA, Growdon JH, Wurtman RJ. 1993. Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc Natl Acad Sci 90: 5191-5193.
130. Nixon RA. 2007. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120: 4081-4091.
131. Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, Lah JJ. 2006. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 26: 1596-1603.
132. Pasternak SH, Callahan JW, Mahuran DJ. 2004. The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective. J Alzheimers Dis 6: 53-65.
133. Pastorino L, Ikin AF, Nairn AC, Pursnani A, Buxbaum JD. 2002. The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta). Mol Cell Neurosci 19: 175-185.
134. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, StokinGB, Koo EH. 1999. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274: 18851-18856.
135. Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH. 2002. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 21: 5691-5700.
136. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH. 2004. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 24: 4259-4265.
137. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, et al. 2004. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113: 1456-1464.
138. Prokop S, Shirotani K, Edbauer D, Haass C, Steiner H. 2004. Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J Biol Chem 279: 23255-23261.
139. Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, Kametani F, Maeda M, Saido TC, Wang R, et al. 2005. Longer forms of amyloid beta protein: Implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25: 436-445.
140. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. 2001. A default mode of brain function. Proc Natl Acad Sci 98: 676-682.
141. Rajendran L, Schneider A, Schlechtingen G, Weidlich S, Ries J, Braxmeier T, Schwille P, Schulz JB, Schroeder C, Simons M, et al. 2008. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 320: 520-523.
142. Rawson RB. 2002. Regulated intramembrane proteolysis: From the endoplasmic reticulum to the nucleus. Essays Biochem 38: 155-168.
143. Rechards M, Xia W, Oorschot VM, Selkoe DJ, Klumperman J. 2003. Presenilin-1 exists in both pre-and post-Golgi compartments and recycles via COPI-coated membranes. Traffic 4: 553-565.
144. Ribaut-Barassin C, Dupont JL, Haeberle AM, Bombarde G, Huber G, MoussaouiS, Mariani J, Bailly Y. 2003. Alzheimer's disease proteins in cerebellar and hippocampal synapses during postnatal development and aging of the rat. Neuroscience 120: 405-423.
145. Riddell DR, Christie G, Hussain I, Dingwall C. 2001. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11: 1288-1293.
146. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, et al. 2001. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer's disease therapeutics. Hum Mol Genet 10: 1317-1324.
147. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, et al. 2007. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genet 39: 168-177.
148. Sano Y, Nakaya T, Pedrini S, Takeda S, Iijima-Ando K, Iijima K, Mathews PM, Itohara S, Gandy S, Suzuki T. 2006. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. PLoS One 1: e51.
149. Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM, Teplow DB, Haass C. 2001. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2: 835-841.
150. Schenk D, Basi GS, Pangalos MN. 2011. Treatment strategies targeting amyloid beta-protein. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006387.
151. Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, Andersen OM, Willnow TE. 2007. SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 282: 32956-32964.
152. Selkoe DJ. 2001. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81: 741-766.
153. Selkoe D, Kopan R. 2003. Notch and presenilin: Regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26: 565-597.
154. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, et al. 1992. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359: 325-327.
155. Shah S, Lee SF, Tabuchi K, Hao YH, Yu C, LaPlant Q, Ball H, Dann CE 3rd., Sudhof T, Yu G. 2005. Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122: 435-447.
156. Sheng JG, Price DL, Koliatsos VE. 2002. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J Neurosci 22: 9794-9799.
157. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, et al. 1992. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258: 126-129.
158. Simons M, Ikonen E, Tienari PJ, Cid AA, Monning U, Beyreuther K, Dotti CG. 1995. Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites. J Neurosci Res 41: 121-128.
159. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, et al. 1999. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402: 537-540.
160. Sisodia SS. 1992. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci 89: 6075-6079.
161. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL. 1990. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
162. Sisodia SS, Koo EH, Hoffman PN, Perry G, Price DL. 1993. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci 13: 3136-3142.
163. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, SalterMW, Lombroso PJ, Gouras GK, Greengard P. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8: 1051-1058.
164. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156: 1051-1063.
165. Steiner H, Fluhrer R, Haass C. 2008. Intramembrane proteolysis by gamma-secretase. J Biol Chem 283: 29627-29631.
166. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr., Eckman C, Golde TE, Younkin SG. 1994. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1336-1340.
167. Szodorai A, Kuan YH, Hunzelmann S, Engel U, Sakane A, Sasaki T, Takai Y, Kirsch J, Muller U, Beyreuther K, et al. 2009. APP anterograde transport requires Rab3A GTPase activity for assembly of the transport vesicle. J Neurosci 29: 14534-14544.
168. Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, Ihara Y. 2009. Gamma-secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29: 13042-13052.
169. Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT, GourasGK. 2010. Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 30: 14299-14304.
170. Tarassishin L, Yin YI, Bassit B, Li YM. 2004. Processing of Notch and amyloid precursor protein by gamma-secretase is spatially distinct. Proc Natl Acad Sci 101: 17050-17055.
171. Tian Y, Bassit B, Chau D, Li YM. 2010. An APP inhibitory domain containing the Flemish mutation residue modulates gamma-secretase activity for Abeta production. Nat Struct Mol Biol 17: 151-158.
172. Tienari PJ, De SB, Ikonen E, Simons M, Weidemann A, Czech C, Hartmann T, IdaN, Multhaup G, Masters CL, et al. 1996. The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein. Embo J 15: 5218-5229.
173. Trommsdorff M, Borg JP, Margolis B, Herz J. 1998. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 273: 33556-33560.
174. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, StricklandDK. 2000. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275: 7410-7415.
175. Vassar R. 2004. BACE1: The beta-secretase enzyme in Alzheimer's disease. J Mol Neurosci 23: 105-114.
176. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741.
177. Vetrivel KS, Meckler X, Chen Y, Nguyen PD, Seidah NG, Vassar R, Wong PC, Fukata M, Kounnas MZ, Thinakaran G. 2009. Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J Biol Chem 284: 3793-3803.
178. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U. 2004. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117: 4435-4448.
179. Wahle T, Prager K, Raffler N, Haass C, Famulok M, Walter J. 2005. GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network. Mol Cell Neurosci 29: 453-461.
180. Wahle T, Thal DR, Sastre M, Rentmeister A, Bogdanovic N, Famulok M, HenekaMT, Walter J. 2006. GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide. J Neurosci 26: 12838-12846.
181. Walter J, Fluhrer R, Hartung B, Willem M, Kaether C, Capell A, Lammich S, Multhaup G, Haass C. 2001. Phosphorylation regulates intracellular trafficking of beta-secretase. J Biol Chem 276: 14634-14641.
182. Wang R, Meschia JF, Cotter RJ, Sisodia SS. 1991. Secretion of the β/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem 266: 16960-16964.
183. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R. 2010. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13: 190-196.
184. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K. 1989. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57: 115-126.
185. Weidemann A, Paliga K, U, D., Reinhard FB, Schuckert O, Evin G, Masters CL. 1999. Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 274: 5823-5829.
186. Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, Masters CL, Beyreuther K, Evin G. 2002. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41: 2825-2835.
187. Weskamp G, Cai H, Brodie TA, Higashyama S, Manova K, Ludwig T, Blobel CP. 2002. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol 22: 1537-1544.
188. Wild-Bode C, Fellerer K, Kugler J, Haass C, Capell A. 2006. A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J Biol Chem 281: 23824-23829.
189. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C. 2006. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314: 664-666.
190. Willem M, Lammich S, Haass C. 2009. Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin Cell Dev Biol 20: 175-182.
191. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513-517.
192. Yamazaki T, Selkoe DJ, Koo EH. 1995. Trafficking of cell surface beta-amyloid precursor protein: Retrograde and transcytotic transport in cultured neurons. J Cell Biol 129: 431-442.
193. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, et al. 1999. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402: 533-537.
194. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, et al. 2000. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54.